Compare Humana Inc (HUM) vs Microsoft (MSFT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Microsoft — how do they compare? Humana Inc trades at $404.09 (market cap $47.81B), while Microsoft trades at $400.14 (market cap $2.99T). The key difference: Microsoft is far larger — about 62.5× Humana Inc's market cap, and Microsoft pays the higher dividend (0.9%). Which is the better fit depends on your goals.
| HUM | MSFT | |
|---|---|---|
Market Cap | $47.81B | $2.99T |
Sector | Health | Technology |
52-Week High | $409.42 | $542.07 |
52-Week Low | $163.67 | $352.83 |
Enterprise Value | $56.85B | $2.97T |
Dividend Yield | 0.89% | 0.9% |
Volume | — | 36,654,621 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Microsoft (MSFT) trades at $399.06, up 1.33% today, with a bullish technical signal and strong fundamentals. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $4.27 exceeding the $4.06 estimate. Revenue growth remains solid, reaching $281.72B in 2025, while profitability metrics like a 39.34% net income margin highlight operational strength. Analyst sentiment is overwhelmingly positive, with an 80.49% buy rating and a $546.70 consensus price target, suggesting significant upside from current levels.
The outlook for Microsoft is favorable, driven by AI leadership, cloud expansion, and consistent execution. Key opportunities include Azure momentum and Copilot adoption, but risks involve high capital expenditures, competitive pressures, and market volatility. With a P/E of 23.96, the stock trades at a premium relative to historical averages, yet growth prospects support investor confidence. Near-term resistance lies at $400, with support at $390.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Microsoft
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →
